HybridStat (www.hybridstat.gr) is a Bioinformatics company located in Athens, Greece, bringing together a team of highly qualified and motivated young scientists, whose expertise spans a variety of statistics and computer science domains. Main HybridStat’s services are centered on bioinformatics, biostatistics and analytics of high-throughput data derived from modern biological technologies such as Next Generation Sequencing (NGS), DNA/miRNA/protein microarrays and mass spectrometry. In addition, HybridStat offers customized software solutions regarding the above. The HybridStat team members have extended and demonstrated experience on research projects, where bioinformatics and biostatistical analysis as well as the development of new analysis techniques, algorithms and software had a crucial role. Apart from bioinformatics, the HybridStat team has a strong background on information personalization and recommendation technologies, as well as big data concepts.

In addition, HybridStat develops Geniasis™ (https://geniasis.com), a cloud-based medical decision support system which is based on the analysis of modern clinical Next Generation Sequencing data. Its goal is the support of accurate diagnostics towards the derivation of personalized medical treatment plans. The platform exploits open source algorithms and open data coupled with a proprietary optimized analysis workflow and data annotation system which provides accurate filtered results. In this way, clinical geneticists and biologists are able to reach timely conclusions and diagnoses. The Geniasis platform has acquired its first customers and has entered production mode. At the same time, new features and functionalities are continuously being added.